QNCX
Quince Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.36 / 10
Netural
Money flow analysis shows an excellent 8.16/10, with positive inflows across all scales (overall, block, small, medium, large, extra-large), hinting at strong institutional accumulation. Analyst sentiment is cautiously optimistic with a 2.56 historical weighted rating and a mix of Neutral and Strong Buy views. This combination of strong fund inflows and balanced analyst opinions provides some support, but it may not offset the negative fundamental and technical trends.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
33%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-30
InstitutionD. Boral Capital
Times predicted10
Historical Win Rate40.0%
What is the market sentiment for QNCX?
- QNCX holds a Bearish analyst rating, with 33% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.36/10 (Netural).
